Source: FinanzNachrichten

ImCyse: Imcyse Enters into Research Collaboration and License Agreement for its Imotope Technology with Pfizer in Rheumatoid Arthritis

Imcyse and Pfizer to collaborate to develop ImotopeTM candidates to potentially treat Rheumatoid Arthritis Pfizer to lead clinical development and commercialization activities Imcyse to receive up...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Denis Bedoret's photo - CEO of Imcyse

CEO

Denis Bedoret

CEO Approval Rating

90/100

Read more